Metraipolis › archive › dc_659c2aba9c7b

How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count — Europe PMC PMID:41089290

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41089290
DOI
10.3389/fendo.2025.1654365
License (as archived)
solo-consultazione
Archived
2026-11-09T16:54:03.655Z
SHA-256 of the archived text
36f7e8be551462baedde8ab7c2ec1ccda14b0b38dd83967294c9eb7e780da23b
Stable URL of this page
https://metraipolis.com/documento/dc_659c2aba9c7b

How to cite

How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count — Europe PMC PMID:41089290 — Europe PMC (en), https://europepmc.org/article/MED/41089290 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_659c2aba9c7b (Metraipolis archive dc_659c2aba9c7b, sha256 36f7e8be551462baedde8ab7c2ec1ccda14b0b38dd83967294c9eb7e780da23b)
BibTeX
@misc{dc659c2aba9c7b,
  title = {How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count — Europe PMC PMID:41089290},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41089290},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_659c2aba9c7b; sha256 36f7e8be551462baedde8ab7c2ec1ccda14b0b38dd83967294c9eb7e780da23b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089290. Agents can read the archived copy with the MCP tool read_document.